Interview with Nancy Sondag: Drama therapy for persons with dementia on a secured unit in an assisted living facility during a pandemic

2021 ◽  
Vol 7 (1) ◽  
pp. 137-143
Author(s):  
Sally Bailey
2021 ◽  
Vol 94 ◽  
pp. 104375
Author(s):  
Emmanuel Chiebuka Okoye ◽  
Christopher Olusanjo Akosile ◽  
Fatai Adesina Maruf ◽  
Ifeoma Uchenna Onwuakagba ◽  
Ukamaka Gloria Mgbeojedo

Author(s):  
Pauline Karikari-Martin ◽  
Lirong Zhao ◽  
Lynn Miescier

Background In 2016, Medicare finalized the Service Intensity Add-on (SIA) payment policy to increase the intensity of hospice registered nurse (RN) or social worker (SW) visits in the last 7 days of life. The research objective was to compare the intensity of hospice RN or SW visits in the last 7 days of life among older decedents who received a hospice visit, while residing in a traditional home, an assisted living facility, or long-term nursing home. Methods A retrospective analysis using 2016-2018 Medicare data of decedents 65 years or older (n= 2 067 863) related to the Medicare SIA payment policy. Intensity was defined as the number and duration of hospice RN or SW visits in the last 7 days of life using Medicare claims code G0299 and G0155. Results Regression results suggest that decedents who received a SIA related visit while residing in an assisted living facility, had on average a slightly longer duration of hospice RN visits in the last 7 days of life, compared to decedents residing in a traditional home, after controlling for demographics and other factors (P<.0001). The duration of hospice RN visits remained unchanged among decedents who received a SIA visit in 2017 or 2018, when compared to 2016 (P <.0001). Overall the average number of hospice SW visits did not differ by place of residence among decedents who received a SIA visit. Conclusions Among decedents who received a SIA related visit, the duration of hospice RN visits were slightly different by place of residence.


2000 ◽  
Vol 21 (1) ◽  
pp. 125-142
Author(s):  
Kenneth Clow ◽  
David O'Bryan ◽  
Jane O'Bryan

2015 ◽  
Vol 63 (3) ◽  
pp. 594-596
Author(s):  
Preeti Kohli ◽  
Alicia I. Arbaje ◽  
Bruce Leff ◽  
Deborah Statom ◽  
Matthew McNabney

2015 ◽  
Vol 30 (4) ◽  
pp. 373-379 ◽  
Author(s):  
Deborah B. Hummer ◽  
Susan G. Silva ◽  
Tracey L. Yap ◽  
Mark Toles ◽  
Ruth A. Anderson

2012 ◽  
Vol 2 (5) ◽  
pp. 115-118
Author(s):  
C. Brock Woodis ◽  
David Fuentes ◽  
Lorraine Sease

Clinicians frequently encounter the use of antipsychotic medications in elderly patients with Alzheimer's dementia (AD). The use of these agents may be a concern since they are not approved by the Food and Drug Administration (FDA) for the treatment of AD and have been shown to increase mortality in the elderly population. This case report focuses on the gradual de-escalation of antipsychotic medications in an 80 year-old female with AD residing in an assisted living facility who was prescribed three antipsychotic medications to help manage behavioral and psychotic symptoms consistent with progressing AD. Following a request by the assisted living facility, a local family medicine practice assessed the resident's treatment regimen. A collaborative consultation between the family medicine practice's clinical pharmacist, the family medicine physician, and the health care providers at the assisted living facility resulted in the decision to gradually discontinue each antipsychotic agent at subsequent facility visits by the family medicine team.


Sign in / Sign up

Export Citation Format

Share Document